Navigating the immunometabolic heterogeneity of B cells in murine hepatocellular carcinoma at single cell resolution
International Immunopharmacology · 2023-07 · 120 · 110257
DOI: 10.1016/j.intimp.2023.110257 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-07. Verfasst von Xindong Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province 310003, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Induction of antitumor immunity is critical for the therapeutic efficacy of hepatocellular carcinoma (HCC) immunotherapy. The cellular metabolic state underpins the effector function of immune cells, yet our understanding of the phenotypic and metabolic heterogeneity of B cells within HCC microenvironment is poorly developed. Herein, we investigated the composition, distribution, phenotype, function and metabolic profiles of B-cell subsets in HCC and adjacent liver tissues from an orthotopic HCC mouse model using single-cell RNA sequencing (scRNA-seq). Our results identified six B-cell clusters, which can be classified into plasma cells and activated and exhausted B cells according to marker expression, functional and temporal distribution. Exhausted B cells exhibited low metabolic activities and impaired effector functions. Activated B and plasma cells showed higher metabolic activity than exhausted B cells, but there were clear differences in their metabolic profiles. In addition, we found that the effector function of exhausted B cells was further diminished in HCC tissues compared with adjacent liver tissues, but their metabolic activity was significantly enhanced. Collectively, we comprehensively characterized the metabolic profile and alterations in B-cell subsets in HCC, which contributes to the understanding of B-cell immunology in HCC and lays the foundation for exploring novel targets in HCC immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province 310003, China.
- Department of Emergency Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province 310003, China; The Key Laboratory for Diagnosis and Treatment of Aging and Physic…
- Department of Health Care, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province 310003, China.
- Department of Ultrasound Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province 310003, China.
- Department of Ultrasound Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province 310003, China. Electronic address: jqliu97@zju.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Zhao, X., Zhang, H., Han, Y., Fang, C., & Liu, J. (2023). Navigating the immunometabolic heterogeneity of B cells in murine hepatocellular carcinoma at single cell resolution. International Immunopharmacology, 120, 110257. https://doi.org/10.1016/j.intimp.2023.110257
Vancouver
Zhao X, Zhang H, Han Y, Fang C, Liu J. Navigating the immunometabolic heterogeneity of B cells in murine hepatocellular carcinoma at single cell resolution. International Immunopharmacology. 2023;120:110257. doi:10.1016/j.intimp.2023.110257
BibTeX
@article{Zhao2023,
author = {Zhao, Xindong and Zhang, Huanran and Han, Yiru and Fang, Chengyu and Liu, Jingqi},
title = {Navigating the immunometabolic heterogeneity of B cells in murine hepatocellular carcinoma at single cell resolution},
journal = {International Immunopharmacology},
year = {2023},
volume = {120},
pages = {110257},
doi = {10.1016/j.intimp.2023.110257}
}
EUVIMED